Alle Studien
Noch nicht rekrutiertBEOBACHTEND

Vascular Health and Function in Cystic Fibrosis

Thanks to modern medicines called CFTR modulators, people with cystic fibrosis (CF) are living longer, fuller lives. Because of this welcome change, doctors want to understand how growing older with CF affects the heart, blood vessels, and brain. This study compares the blood vessel health of adults with CF aged 40 and older with healthy adults of the same age and sex. Researchers want to see if blood vessels work differently in people with CF and whether this affects brain blood flow, memory, or mood. Taking part involves a single visit lasting around two and a half to three hours at a hospital in Liverpool or a university clinic in Manchester. Participants will have simple, painless ultrasound scans, basic heart and breathing checks, a routine blood test, and short memory puzzles. No new medications are tested, and taking part will not change your normal healthcare.

Auf einen Blick

Status
Noch nicht rekrutiert
Sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust
Einschreibeziel
100
Starten
10 Oct 2026
Geschätzte Fertigstellung
01 Jul 2030

Worum geht es in dieser Studie?

In recent years, modern treatments known as CFTR modulators have transformed life for people with cystic fibrosis (CF). Because people are living longer into adulthood, doctors are now turning their attention to conditions that tend to appear as we age, including heart and blood vessel problems.

This observational study aims to explore how CF affects the body's circulation. Researchers want to compare blood vessel health between people with CF who are 40 or older and healthy volunteers of a similar age. They will look closely at how well the arteries in your arm and neck expand and contract, and how smoothly blood travels up to the brain during daily activities like standing up.

The research team will also check blood samples for signs of inflammation (the body's natural response to irritation or infection) and stress in the cells. In addition, they will look at whether blood vessel health is linked to day-to-day well-being, mood, and memory.

Because this is an observational study, you will not be asked to try any new medicines or change your existing care. The information gathered will help doctors understand cardiovascular health in people with CF, paving the way for better long-term care and advice in the future.

Wichtige Erkenntnisse

  • The study explores how cystic fibrosis affects blood vessels, heart health, and brain circulation in adults aged 40 and older.
  • It compares adults with CF who take CFTR modulators against healthy volunteers of the same age and sex.
  • Participation involves just one visit lasting approximately 2.5 to 3 hours at a clinic in Liverpool or Manchester.
  • Assessments include non-invasive ultrasound scans, breathing checks, a blood test, and brief memory tasks.
  • No new medicines are being tested, and taking part will not disrupt your usual daily care.

Wer könnte berechtigt sein?

This study is open to men and women aged 40 and older who fall into one of two groups. The first group includes people with a confirmed diagnosis of cystic fibrosis who are taking CFTR modulator therapy and have been in stable health for at least four weeks (with no chest flare-ups or hospital stays). The second group includes healthy volunteers of a similar age and sex who do not take regular prescription medicines, apart from HRT or contraception.

To keep tests safe and results reliable, certain people cannot take part. You cannot join if you have had a stroke, a heart attack in the last three months, heart valve problems, an organ transplant, active cancer, or an uncontrolled thyroid condition. People with long-term inflammatory conditions, such as rheumatoid arthritis or lupus, are also excluded.

Additionally, you cannot take part if you currently smoke or vape, or if you have smoked or vaped within the last ten years. The study is also not suitable for anyone who is pregnant, breastfeeding, taking regular steroid tablets or blood vessel medications, or has high blood pressure at the clinic visit.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Are you 40 years of age or older?
  2. Do you have cystic fibrosis and take a CFTR modulator, OR are you in good health and take no regular prescription medicines?
  3. Have you been free from chest infections or hospital stays for at least the last 4 weeks?
  4. Have you been completely smoke-free and vape-free for the past 10 years?
  5. Are you free from a history of stroke, recent heart problems, or organ transplants?
  6. Are you able to attend a single 3-hour visit in Liverpool or Manchester?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

Taking part involves a single visit lasting about two and a half to three hours. This visit takes place at Liverpool Heart and Chest Hospital, though some healthy volunteers may attend Manchester Metropolitan University instead. There are no follow-up visits or home tasks once your appointment is finished.

During the visit, researchers will: • Measure your height, weight, waist, and body fat percentage. • Take a routine blood sample to check general health, cholesterol, and inflammation markers. • Perform painless ultrasound scans on the arteries in your arm and neck. This includes wearing a snug blood pressure cuff on your wrist for five minutes and resting your hand in cool water for three minutes. • Monitor your heart rhythm, blood pressure, and breathing while you rest, stand up, do a few gentle squats, and open or close your eyes. • Ask you to complete brief memory puzzles and short questionnaires about your mood and quality of life.

You will not be given any experimental medicines, and your normal treatment plan will not change.

Potenzielle Risiken und Vorteile

You will not receive any direct medical treatment or personal health benefits from taking part. However, your participation will help doctors better understand how to protect heart and brain health in people ageing with cystic fibrosis. The assessments carry very low risk. You might feel slight, brief discomfort from the blood test needle, the tightness of the wrist cuff, or resting your hand in cool water. The squatting exercise is gentle, but you can rest if you feel tired or lightheaded. Taking part is entirely voluntary, and you are free to stop the tests or leave the study at any time without it affecting your standard medical care.

Standorte (1)

  • Liverpool Heart and Chest Hospital NHS Foundation Trust
    Verifizierte Postleitzahl
    Liverpool, United Kingdom

Häufige Fragen

Will taking part change my usual cystic fibrosis treatments?

No. You will continue to take your regular CFTR modulators and other prescribed medicines as normal. The study does not test any new treatments.

Do any of the tests hurt?

Most tests are completely painless. You may feel a brief pinch during the routine blood test, some pressure when the wrist cuff is inflated, or mild coolness when your hand is placed in cool water.

How many appointments do I need to attend?

You only need to attend one single appointment. It will last roughly two and a half to three hours.

What if I feel unwell or have a chest infection before my visit?

You must be clinically stable with no chest flare-ups or hospital stays for at least four weeks before your visit. If you become unwell, let the team know so they can reschedule your appointment for when you are fully recovered.

Kann ich die Studie verlassen, wenn ich meine Meinung ändere?

Yes. You can withdraw from the study at any point, even during the visit, without giving a reason. Your standard NHS care will not be affected in any way.

Wie Sie mehr erfahren können

Freddy Frost

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "Vascular Health and Function in Cystic Fibrosis… wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.